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Abstract: Bipolar disorder is a serious mental illness characterized by alternating periods 
of elevated and depressed mood. Sleep disturbances in bipolar disorder are present during all 
stages of the condition and exert a negative impact on overall course, quality of life, and treat-
ment outcomes. We examine the partnership between circadian system (process C) functioning 
and sleep–wake homeostasis (process S) on optimal sleep functioning and explore the role of 
disruptions in both systems on sleep disturbances in bipolar disorder. A convergence of evidence 
suggests that sleep problems in bipolar disorder result from dysregulation across both process C 
and process S systems. Biomarkers of depressive episodes include heightened fragmentation of 
rapid eye movement (REM) sleep, reduced REM latency, increased REM density, and a greater 
percentage of awakenings, while biomarkers of manic episodes include reduced REM latency, 
greater percentage of stage I sleep, increased REM density, discontinuous sleep patterns, short-
ened total sleep time, and a greater time awake in bed. These findings highlight the importance 
of targeting novel treatments for sleep disturbance in bipolar disorder.
Keywords: bipolar disorder, circadian rhythms, sleep–wake homeostasis
Introduction
Bipolar disorder: a background
Bipolar disorder, a severe and chronic mental illness with a lifetime prevalence of 
~1.0%,1 is characterized by alternating episodes of depressed and elevated mood.2 
Regarded as the sixth leading cause of disability internationally,3 bipolar disorder 
is associated with standard mortality rates ranging from 1.9 to 2.1,4 resulting from 
cardiovascular disease (CVD), diabetes mellitus, pneumonia, influenza, chronic pul-
monary obstructive disease, and suicide, among other factors.5 Research indicates that 
>50% of bipolar patients experience one or more medical comorbidities associated 
with poor health behaviors (eg, physical inactivity and cigarette smoking), side effects 
from pharmacological treatments (eg, weight gain), and nonadherence to established 
treatment regimens.6 Many bipolar patients also suffer from comorbid psychiatric 
conditions such as anxiety disorders and substance-use disorders.1,7 In addition to 
increasing mortality risk, such comorbidities result in reduced quality of life and overall 
poor mental health, thus contributing to continued mood symptoms and a worsened 
course of bipolar illness.1,4,6,8
Bipolar disorder is largely considered in terms of two diagnostic subtypes that vary 
with regard to mood episode characteristics, presentation, and  episode severity. The first 
subtype, bipolar I disorder, is marked by one or more lifetime episodes of mania or a 
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continuously elevated or irritable mood. Episodes of mania 
are characterized by at least 1 week of specific symptoms 
such as perceptions of grandiosity, increased flight of ideas, 
racing thoughts, increased talkative behaviors, reduced need 
for sleep, impulsive behaviors, distractibility, and heightened 
risk-taking that impairs one’s ability to function.2 Many 
patients with bipolar I disorder also experience periods of 
depressed mood. Bipolar II disorder is characterized by 
one or more episodes of hypomania or a period of elevated 
mood lasting for only 4 days and with fewer symptoms than 
mania and is not associated with any impairment. Patients 
with bipolar II disorder also have experienced at least one 
major depressive episode.2 Given that sleep disruptions are 
key symptoms of both the manic and depressive phases of 
bipolar I and II disorders, we chose to consider bipolar I and 
II together for the purposes of this manuscript.
Bipolar disorder and sleep disturbances
Sleep disturbances are highly prevalent among bipolar 
patients and exert a detrimental impact on course of illness, 
self-reported quality of life, functioning, symptom burden, 
and overall treatment outcomes.9–11 Sleep disturbances are 
often highly comorbid with other psychiatric conditions 
and maladaptive health behaviors such as substance-use 
disorders,12 anxiety disorders,13 increased weight and obesity, 
and lack of physical activity.12 Such sleep disturbances occur 
across all stages of the illness such as directly preceding 
a mood episode and during an acute mood episode (eg, a 
depressive, manic, or mixed episode). Further, sleep distur-
bances are not unique to symptomatic bipolar patients; studies 
have noted the presence of sleep problems in euthymic (or 
remitted) bipolar patients,9,14 highlighting the importance 
of sleep as a treatment target throughout all stages of the 
bipolar illness.
Sleep disturbances can manifest differently at various 
stages of the illness. During mania or hypomania, sleep 
disruptions are commonly presented as a reduced need for 
sleep with studies finding that 69%–99% of bipolar individu-
als report a lessened need for sleep during a manic episode 
or difficulties in falling and/or staying asleep.15 During 
depression, sleep disruptions are commonly exhibited as 
hypersomnia or excessive sleepiness. Hypersomnia is highly 
prevalent in bipolar disorder with rates ranging from 38% to 
78% of bipolar patients.16 However, bipolar depression is also 
often characterized with severe insomnia.15 Importantly, this 
sleep disturbance is associated with worse course of illness. 
For example, sleep disturbances were cited as the most com-
mon prodrome for a manic episode.17,18 Studies have found 
the onset of sleep disturbances to predate the experience of 
the affective symptoms that characterize bipolar disorder.19
The high rates of sleep disturbance in individuals with 
bipolar disorder, its pervading presence across the subtypes 
and stages of this condition, and its deleterious impact on 
its course raise an important question: Why does sleep seem 
to be at the root of bipolar disorder? If we could answer this 
question, it may lead to answers in how to treat this complex 
and chronic condition more effectively. To that end, this 
manuscript investigates the mechanisms and pathways con-
tributing to sleep disturbances in bipolar patients. Broadly, 
individuals with bipolar disorder may possess a certain 
genetic predisposition for sleep problems; this predisposi-
tion may subsequently contribute to an abnormal shift or 
dysregulation within the bipolar individual’s circadian rhythm 
systems.9,20,21 This manuscript will examine the factors influ-
encing sleep disturbances in bipolar disorder, biomarkers of 
sleep disturbances across various bipolar episodes, and the 
role of sleep disturbances in bipolar episode relapse.
Circadian systems and sleep–wake 
homeostasis: an overview
A widely accepted explanation for sleep disturbances in 
bipolar disorder rests on a circadian system model, which 
posits that sleep problems among bipolar patients result 
from dysregulated circadian rhythms.20 Circadian rhythms 
are biological processes that adopt an ~24-hour cycle or 
rhythm.21 Such biological processes include internal body 
temperature regulation, feeding activity, hormone secretion, 
the sleep–wake rhythm, and overall mood.22 Rhythms are 
considered to be circadian if they occur without external cues 
or if they are endogenous (eg, originate internally).21 Thus, 
circadian rhythms are an innate system that allows the body 
to maintain the processes critical to survival, health, and 
overall functioning (eg, hormones, sleep, and temperature).21
Circadian rhythms are regulated via the suprachiasmatic 
nucleus (SCN) in the anterior hypothalamus above the optic 
chiasm. Commonly referred to as the “master clock” or the 
“master pacemaker”, the SCN is responsible for overseeing 
circadian rhythms with assistance from several peripheral 
clocks in various cells, tissues, and organs.20,23 Our internal 
clock is synchronized with the external world through zeit-
gebers, which are environmental cues that provide the neces-
sary stimulus to entrain to the 24-hour light/dark cycle.21,24 
The SCN, for instance, is highly sensitive to light, a photic 
zeitgeber.20,23 Zeitgebers that are especially relevant to the 
peripheral clocks include eating schedules, social activities, 
and physical activity. As discussed further subsequently, 
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failed synchronizing between these internal rhythms and 
external cues may be a key factor disrupting circadian sys-
tems, leading to mood episodes25 and sleep disruptions in 
bipolar patients.20,21,26
In healthy organisms, the neurobiological processes 
underlying circadian systems follow a characteristic pattern. 
Photic inputs (eg, light-related inputs) are transported from 
the retina to the SCN across the retinohypothalamic tract. 
The SCN projects to several hypothalamic nuclei and to a 
broad array of neural areas22 with the SCN also receiving 
nonphotic input from various brain regions. The SCN inte-
grates the photic and nonphotic inputs to create a signal that 
helps maintain the organism’s overall functioning (eg, body 
temperature and sleep–wake cycle).27 In addition, the SCN 
moderates the production of melatonin and cortisol, which 
are hormones that serve an important role in the timing of 
sleep and help maintain the sleep–wake cycle.28,29
The sleep–wake cycle is importantly regulated not only 
through a circadian system process (process C) but also 
through the process of sleep–wake homeostasis (process S). 
This process ensures that the drive, or need, for sleep pro-
gressively increases with continued wakefulness such that, 
the longer that one has been awake, the greater the drive for 
sleep. The need for sleep typically is at its maximum in the 
evening (eg, bedtime). The converse also holds true; increased 
sleep is associated with a decreased need for sleep. Thus, 
sleep–wake homeostasis is an important process regulat-
ing sleep time and duration. Data suggest that adenosine, 
a neurotransmitter, serves an important role in sleep–wake 
homeostasis as adenosine levels rise during increased periods 
of wakefulness (resulting in an increased need for sleep) and 
fall during increased periods of sleep (resulting in a decreased 
need for sleep).30–35
Circadian rhythm disruptions in 
bipolar disorder
Recent research has determined that a nonadaptive circadian 
system is a biomarker of bipolar disorder.36 Specifically, 
individuals with bipolar disorder have weakly entrained cir-
cadian systems, which contribute to their mood episodes and 
impact their social rhythms such as sleep and meal timing.37 
According to a circadian rhythm disruption model of bipolar 
disorder, abnormal circadian rhythms interact with various 
competing social zeitgebers, leading to mania (characterized 
by behavioral activation) or depression (characterized by 
behavioral inhibition).24,37 In one study, Malkoff-Schwartz 
et al38 found that life events that caused social rhythm disrup-
tions were associated with the onset of manic episodes.37,38 
Evidence of circadian rhythm disruptions has been cited 
in several studies of bipolar disorder. For example, in one 
study, euthymic bipolar patients had decreased melatonin 
secretion as well as a delayed peak time of melatonin at 
night compared to healthy control participants.28 In another 
study, bipolar patients in depressed and hypomanic stages 
of illness exhibited increased cortisol secretion relative to 
healthy control subjects.39 Light exposure has also been 
associated with abnormal melatonin secretion patterns (eg, 
low melatonin levels) in patients with bipolar I disorder, sug-
gesting an abnormality in their circadian rhythm system.28 
Circadian genes such as CLOCK, TIMELESS, ARNTL2, and 
DBP have also demonstrated an association with circadian 
phenotypes established in bipolar disorder.40 More recently, 
animal models with defective clock genes such as CLOCK 
and Nr1d1 have supplied new insight into the molecular 
pathways that underlie both mood dysfunctions and sleep 
disturbances. Findings suggest that mice with an altered 
CLOCK gene (eg, a deletion of exon 19) demonstrate manic-
like behaviors, increased hyperactivity, reduced need for 
sleep, and heightened reward-seeking behaviors.41,42 Further 
study of the CLOCK gene will supply increased insight 
into the associations linking circadian disruptions, mood 
disturbances, and abnormal sleep patterns. In addition, the 
Rev-erbalpha protein, which is encoded by the Nr1d1 gene, 
serves an important role in circadian rhythm regulation and 
generation.43 Mang et al43 examined electroencephalography 
(EEG) data in Rev-erbalpha knockout (KO) and wild-type 
mice during baseline, sleep deprivation, and recovery with 
cortical gene expression postsleep deprivation compared to 
baseline values. Findings indicated that a lack of Rev-erbal-
pha had an impact on the KO mice’s homeostatic regulation of 
sleep; specifically, the KO mice demonstrated reduced EEG 
delta power and a smaller increase in sleep consolidation 
after baseline sleep onset and sleep deprivation, suggestive 
of a slower increase in homeostatic sleep need in periods of 
wakefulness.43 KO mice also demonstrated increased theta 
activity during wakefulness, which predicted delta power in 
nonrapid eye movement sleep; these data are reflective of 
the EEG changes present in mood disorders.43 Future stud-
ies should continue to explore the role of Rev-erbalpha on 
mood regulation and homeostatic regulation of sleep. Finally, 
pharmacotherapy for bipolar disorder may also positively 
influence abnormal circadian rhythms; for instance, lithium 
has shown effectiveness in correcting an abnormal circadian 
cycle length.44
Alterations in the SCN in both cellular and physiologi-
cal domains may relate to bipolar disorders. As discussed 
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earlier, the SCN serves an important role in maintaining cir-
cadian rhythm function by integrating photic and nonphotic 
inputs.27 Among bipolar patients, alterations in the SCN 
may contribute to circadian rhythms that are out of phase 
or of low amplitude,45 such abnormalities may result from 
effects on neurotransmitters.46 One study found alterations 
in arginine vasopressin (AVP) neurons within the SCN of 
depressed patients; specifically, study patients demonstrated 
an increase in AVP-immunoreactive neurons and a decrease 
in AVP-messenger RNA neurons. More broadly, these data 
suggest a pattern of reduced synthesis and release of AVP in 
depression.47 Such findings may also have important implica-
tions for alterations in the SCN within bipolar patients. On 
a physiological level, early studies demonstrated that lesions 
in the SCN contribute to loss of circadian rhythms, thereby 
highlighting the role of the SCN in circadian system regula-
tion and in maintenance of the temporal order of physiologi-
cal processes. Specifically, alterations in the SCN may affect 
the ability of this region to coordinate temporal order of all 
cells, organs, and peripheral clocks. Failed temporal order 
can, in turn, lead to disrupted circadian rhythms.48–50 Indeed, 
failed coordination across the SCN, the peripheral clocks, and 
environmental variables may importantly contribute to bipolar 
illness. A lack of synchronization between the SCN and the 
peripheral clocks contributes to internal desynchronization, 
which can cause physiological responses to occur at incorrect 
times, thereby lead to mood episodes.48 In addition, the SCN 
and peripheral clocks rely on zeitgebers for entrainment of 
circadian rhythms. An absence of zeitgebers or a failure of 
zeitgebers to act on the correct receptors for both the SCN 
and the peripheral clocks can lead to desynchronized circa-
dian rhythms.45
The social zeitgeber theory highlights the importance 
of circadian dysfunction in bipolar disorder. According to 
this theory, disruptions in biological rhythms may be caused 
by disturbances in a given individual’s social routine and 
patterns leading to depression, with accumulating evidence 
that these circadian rhythm disruptions may trigger mania 
as well.21 Thus, sleep may serve as the most robust marker 
of the impact of the disrupted circadian rhythm system on 
mood.
Sleep–wake rhythms as biomarkers 
of bipolar disorder
Sleep in unipolar depression
Most sleep studies for bipolar disorder have compared sleep 
irregularities in this population to individuals with unipolar 
depression (or individuals who do not experience mania or 
hypomania). Thus, we begin with understanding sleep in 
unipolar depression or a reduction in slow wave sleep, rapid 
eye movement (REM) sleep disinhibition, time between 
sleep onset and the occurrence of the first REM period, and 
increased REM density and disruptions in sleep continuity.51 
Some studies have found that, in unipolar depression, the 
circadian rhythms of REM sleep seem to be shifted earlier 
or phase advanced. This finding demonstrated early support 
from Wehr et al52 who cited an antidepressant effect of a 
shifted sleep period for participants who went to sleep and 
woke up earlier than usual. Total sleep deprivation has also 
been found to enhance mood in ~60% of patients with depres-
sion; however, in some cases, this deprivation has been linked 
to a subsequent depressive episode relapse on the following 
night.53,54 Berger et al55 explored the effect of combining 
total sleep deprivation with consecutive sleep phase advance 
therapy for a 1-week period to prevent the depressive relapse 
that tends to follow the antidepressant effect of total sleep 
deprivation. These investigators found that 61% of patients 
who experienced improvements in depressive symptom-
atology following total sleep deprivation maintained these 
improvements during sleep phase advance therapy.55
The literature also suggests that phase-delayed circadian 
misalignment is common in unipolar depression.56–58 Overall, 
studies in unipolar depression have not consistently found circa-
dian rhythms to be either phase advanced or phase delayed.56,59 It 
is thus important to consider the effect of all types of circadian 
misalignment on the course of depressive illness.
Sleep in bipolar depression
Analyses of polysomnography studies in unipolar depression 
compared to bipolar depression have specifically focused on 
the overlap in sleep disturbance symptoms between the two 
conditions.37,51 Compared to unipolar depressed patients, 
depressed bipolar patients demonstrate heightened fragmen-
tation of REM sleep (especially in bipolar I patients), longer 
sleep onset latency, a pattern toward an increased number 
of spindles, a greater percentage of awakenings, and greater 
REM density.60–64 Compared to healthy individuals, depressed 
bipolar patients demonstrate reduced REM latency, increased 
REM density, low sleep continuity, and extended slow-wave 
sleep latency;62,65–68 refer to Harvey20 for a full review. Relative 
to sleep in unipolar depression, sleep in bipolar depression 
is associated with a greater amount of eveningness prefer-
ence69,70 and a larger number of delayed sleep phase cases 
relative to unipolar depression.71
Bipolar patients may respond better to sleep deprivation 
than unipolar patients.13 Bipolar patients have a mismatched 
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biological clock and sleep–wake cycle; sleep deprivation 
helps to correct this mismatch by enhancing sleep–wake 
homeostasis (process S) so as to balance the increased arousal 
of the depressed stage.20 Between 40% to 60% of bipolar 
patients with depression demonstrate improvements in mood 
following sleep deprivation.72
Plante and Winkelman13 note that sleep deprivation could 
be problematic for individuals with bipolar disorder, given 
its association with depression relapse following recovery 
sleep. In addition, sleep deprivation may be associated with 
the occurrence of a mood episode within the opposite pole. 
Among 206 bipolar depressed patients who received three 
cycles of sleep deprivation treatment, Colombo et al73 noted 
that 4.85% of participants exhibited a switch into mania and 
5.83% of participants exhibited a switch into hypomania. 
When given in conjunction with lithium, sleep deprivation 
may be the most beneficial as lithium is effective in correcting 
an abnormal circadian system in some bipolar patients and 
may improve sleep deprivation treatment response.13 Sleep 
deprivation plus bright light therapy,74 or phase shift of the 
sleep period, may also help maintain the treatment effects of 
sleep deprivation.13 It should be noted that a certain genetic 
variant may predispose some patients with bipolar depres-
sion to respond better to the sleep deprivation treatment; 
specifically, Benedetti et al75 found that individuals who were 
homozygous for the long variant of the serotonin transporter 
gene 5-HTTLPR showed better mood improvements follow-
ing sleep deprivation than individuals who were homozygous 
or heterozygous for the short variant.
Sleep in mania
Reduced need for sleep is a Diagnostic and Statistical Manual 
of Mental Disorders, Fifth Edition diagnostic criterion for 
mania and also serves as a marker for the association between 
mania and sleep disturbances. Self-report of decreased need 
for sleep is highly common during acute mania37 and is veri-
fied through polysomnography data. In an interesting early 
finding, Hudson et al76 found significant similarities between 
sleep disturbances in unipolar depression and in acute mania 
among age-matched manic patients and depressed patients 
with both groups of participants demonstrating disrupted 
sleep continuity, reduced REM latency, heightened percent-
age of stage I sleep, and increased REM density relative 
to age-matched controls. This finding suggests that sleep 
disturbances within mania and depression result from 
similar processes.76 Other studies have found a shorter total 
sleep time and a greater time awake in bed among manic 
patients (for a review, see Plante et al13). It should be noted 
that reduced sleep in manic patients may not result from a 
decreased need for sleep, but instead serve as a byproduct of 
the overall hyperactivity that characterizes the manic phase.37 
In many cases, sleep reduction may be an important factor 
leading to a manic episode. As discussed earlier, Colombo 
et al73 found that sleep deprivation as a treatment for bipolar 
depression resulted in a switch to mania or hypomania for a 
percentage of the study sample. These findings were also sup-
ported by Wehr et al77 who found that seven of nine patients 
deprived of sleep for one night experienced subsequent 
mania or hypomania. Wehr et al78 posit that sleep deprivation 
is the “final common pathway” to the experience of mania. 
Several factors contribute to reduced sleep, which in turn 
leads to symptoms of hypomania or mania. This contributes 
to an ongoing cycle as, once the individual is in a manic or 
hypomanic state, a pattern of reduced sleep is maintained.78
Sleep in euthymia
Euthymia has been conceptualized as the remitted time 
between episodes, but often symptoms persist between 
episodes. For example, ~70% of bipolar patients continue 
to experience sleep disturbance even during euthymia.79 
One meta-analysis of several studies found that, compared 
to healthy controls, bipolar individuals during euthymia 
demonstrate significantly longer total sleep time and time 
in bed. Also, during this phase of the condition, there was 
significant variability in total sleep time.80 Several studies 
have found that bipolar patients when euthymic also dem-
onstrate longer sleep-onset latency, increased awakenings 
during the night, increased REM density, and reduced sleep 
efficiency.79,81
Sleep in bipolar disorder: relevance 
and clinical implications
This review highlights the role that sleep has in the etiology 
and maintenance of mood episodes for individuals with 
bipolar disorder. This lends support for sleep disturbance to 
be an important target of research and intervention, espe-
cially given data that sleep disturbances in bipolar disorder 
are also associated with heightened medical burden through 
conditions such as CVD, increased weight, and diabetes mel-
litus12,37 with recent studies highlighting the circadian rhythm 
system as an important factor contributing to the association 
between sleep disturbances and CVD (eg, influence of meal 
timing on insulin resistance and a risk factor for diabetes 
and CVD).37 Sleep deprivation may also be associated with 
poor eating habits in bipolar patients, given the association 
of sleep deprivation with certain hormonally influenced 
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responses that lead to enhanced caloric intake.12 Further, 
sleep disturbances in bipolar disorder are linked to reduced 
energy levels and thus, a lessened likelihood of engaging in 
other healthy behaviors (eg, seeing others, grocery shop-
ping, cooking, and exercising).12 Finally, sleep disturbances 
are linked to increased risk for suicidal ideation and suicide 
attempts among bipolar patients.82 These data highlight the 
many possible clinical implications of improving sleep in 
bipolar disorder.
Sleep disturbances in bipolar disorder may also be an 
important marker for relapse. Sleep disruption is common 
to the euthymic phase of bipolar disorder with studies citing 
the association of poor sleep and cognitive functioning with 
low work performance in euthymic patients,83 increased use 
of sleep medication, reduced daytime functioning, longer 
sleep latency,84 and mood episode recurrence.9 One study 
found poor sleep to predict earlier mood episode recurrence 
independent of any residual mood symptoms. Further, Har-
vey et al85 found that euthymic bipolar patients demonstrated 
clinically significant sleep disturbances, reduced sleep effi-
ciency, low activity levels during the day, and heightened 
fear and anxiety about not sleeping well. Given that sleep 
disturbances are common in euthymic bipolar patients and 
associated with mood episode recurrence, further study of 
the role of sleep disturbances in bipolar episode relapse is 
vital.
Conclusion and future directions
Sleep appears to be a likely biomarker of bipolar disorder, 
given that sleep disturbances persist across the phases of 
the condition (depressive, manic, and euthymic) and leads 
to worse course of illness. Further evidence of sleep as a 
biomarker is drawn from the evidence of other circadian 
rhythm disruptions in bipolar disorder and their effect on the 
condition as well as evidence that sleep manipulations can 
affect the course of the illness. Given the impact of sleep dis-
turbances on bipolar disorder, future research would benefit 
from examining novel psychosocial, pharmacological, and 
technological strategies to improve sleep. Zachariae et al86 
conducted a meta-analysis of Internet-delivered cognitive 
behavioral therapy for insomnia (eCBT-I) with findings indi-
cating that eCBT-I was effective in improving self-reported 
sleep quality, sleep onset latency, sleep efficiency, and total 
sleep time among individuals with insomnia or self-reported 
sleep problems.86 An eCBT-I approach warrants further atten-
tion in a bipolar sample. Harvey et al11 developed a cognitive 
behavioral therapy for insomnia specific to bipolar disorder 
and compared this intervention to a psychoeducational con-
trol group. They found that cognitive behavioral therapy for 
insomnia specific to bipolar disorder lowered overall rate 
of mood episode relapse, rate of hypomania/mania relapse, 
days in a bipolar episode, and lowered insomnia severity 
compared to the control group.11 Sylvia et al87 examined 
an electrocardiogram-based home sleep monitoring device 
(M1) in bipolar patients and found it to improve participants’ 
overall sleep duration. These investigators are currently 
exploring the application of the M1 device in a study of 
cognitive behavioral therapy for sleep problems in bipolar 
disorder. Another recent advance in the study of sleep and 
bipolar disorder is the application of mindfulness-based cog-
nitive therapy for insomnia.88,89 Preliminary data suggest that 
mindfulness could be a helpful adjunct treatment for sleep. 
Indeed, an integrated approach may yield the best findings 
for informing future treatments for individuals with sleep 
disturbances in bipolar disorder.
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